These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30937736)

  • 21. Behavioural treatment to reduce sleep problems in children with autism or fragile X syndrome.
    Weiskop S; Richdale A; Matthews J
    Dev Med Child Neurol; 2005 Feb; 47(2):94-104. PubMed ID: 15707232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral Assessment and Treatment via Telehealth for Children with Autism: From Local to Global Clinical Applications.
    Schieltz KM; O'Brien MJ; Tsami L; Call NA; Lerman DC
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Child Challenging Behavior Influences Maternal Mental Health and Relationship Quality Over Time in Fragile X Syndrome.
    Fielding-Gebhardt H; Warren SF; Brady NC
    J Autism Dev Disord; 2020 Mar; 50(3):779-797. PubMed ID: 31754947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADHD symptoms in children with FXS.
    Sullivan K; Hatton D; Hammer J; Sideris J; Hooper S; Ornstein P; Bailey D
    Am J Med Genet A; 2006 Nov; 140(21):2275-88. PubMed ID: 17022076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inclusive Preschool Practitioners' Implementation of Naturalistic Developmental Behavioral Intervention Using Telehealth Training.
    D'Agostino S; Douglas SN; Horton E
    J Autism Dev Disord; 2020 Mar; 50(3):864-880. PubMed ID: 31802319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study.
    Haessler F; Gaese F; Huss M; Kretschmar C; Brinkman M; Peters H; Elstner S; Colla M; Pittrow D
    BMC Psychiatry; 2016 Sep; 16(1):318. PubMed ID: 27612457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expressed emotion and impulsiveness in mothers of children with Fragile X Syndrome and Down Syndrome: The relation to behavioral problems in their offspring.
    Cregenzán-Royo O; Brun-Gasca C; Fornieles-Deu A
    Res Dev Disabil; 2018 Dec; 83():179-189. PubMed ID: 30240913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMPASS for Hope: Evaluating the Effectiveness of a Parent Training and Support Program for Children with ASD.
    Kuravackel GM; Ruble LA; Reese RJ; Ables AP; Rodgers AD; Toland MD
    J Autism Dev Disord; 2018 Feb; 48(2):404-416. PubMed ID: 29022130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the function of problem behavior in fragile X syndrome: preliminary experimental analysis.
    Langthorne P; McGill P; O'Reilly MF; Lang R; Machalicek W; Chan JM; Rispoli M
    Am J Intellect Dev Disabil; 2011 Jan; 116(1):65-80. PubMed ID: 21291311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.
    Tranfaglia MR
    Dev Neurosci; 2011; 33(5):337-48. PubMed ID: 21893938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.
    Kaufmann WE; Kidd SA; Andrews HF; Budimirovic DB; Esler A; Haas-Givler B; Stackhouse T; Riley C; Peacock G; Sherman SL; Brown WT; Berry-Kravis E
    Pediatrics; 2017 Jun; 139(Suppl 3):S194-S206. PubMed ID: 28814540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral style of young boys with fragile X syndrome.
    Hatton DD; Bailey DB; Hargett-Beck MQ; Skinner M; Clark RD
    Dev Med Child Neurol; 1999 Sep; 41(9):625-32. PubMed ID: 10503921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inferential language use by school-aged boys with fragile X syndrome: Effects of a parent-implemented spoken language intervention.
    Nelson S; McDuffie A; Banasik A; Tempero Feigles R; Thurman AJ; Abbeduto L
    J Commun Disord; 2018; 72():64-76. PubMed ID: 29494850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.
    Hommel KA; Hente E; Herzer M; Ingerski LM; Denson LA
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):469-73. PubMed ID: 23325274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responsive Parenting as a Target for Telehealth Language Interventions in Fragile X Syndrome: Implications for Scalability and Best Practices.
    Bullard L; Abbeduto L
    Semin Speech Lang; 2021 Aug; 42(4):287-300. PubMed ID: 34311481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G
    Am J Med Genet A; 2008 Apr; 146A(7):803-12. PubMed ID: 18286595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavior and autonomic nervous system function assessed via heart period measures: the case of hyperarousal in boys with fragile X syndrome.
    Boccia ML; Roberts JE
    Behav Res Methods Instrum Comput; 2000 Feb; 32(1):5-10. PubMed ID: 10758659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant behaviors of young boys with fragile X syndrome.
    Lachiewicz AM; Spiridigliozzi GA; Gullion CM; Ransford SN; Rao K
    Am J Ment Retard; 1994 Mar; 98(5):567-79. PubMed ID: 8192902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the operant function of challenging behavior in young males with fragile X syndrome: a summary of 12 cases.
    Machalicek W; McDuffie A; Oakes A; Ma M; Thurman AJ; Rispoli MJ; Abbeduto L
    Res Dev Disabil; 2014 Jul; 35(7):1694-704. PubMed ID: 24679547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index.
    Raspa M; Sacco P; Candrilli SD; Bishop E; Petrillo J
    J Intellect Disabil Res; 2016 Sep; 60(9):844-55. PubMed ID: 26929037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.